GW 282974X,
GW 572016,
GW-282974X,
GW-572016,
GW282974X,
GW572016,
lapatinib,
lapatinib ditosylate,
N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine,
Tykerb,
Lapatinib Ditosylate,
388082-77-7,
Tykerb,
Tyverb,
Lapatinib (GW-572016) Ditosylate,
Lapatinib (ditosylate),
N-(3-CHLORO-4-((3-FLUOROBENZYL)OXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)FURAN-2-YL)QUINAZOLIN-4-AMINE BIS(4-METHYLBENZENESULFONATE),
Tykerb Ditosylate,
UNII-4WK72K94MC,
388082-78-8,
4WK72K94MC,
AK-47669,
GW-57201,
bis(4-methylbenzene-1-sulfonic acid); N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine,
GW-572016F Ditosylate,
SR-05000001472,
GW-572016,
Lapatinib ditosylate anhydrous,
Tyverb|||Tykerb,
Lapatinib ditasylate,
Lapatinib-Ditosylate,
GW 572016F,
N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine Bis(4-methylbenzenesulfonate) Ditosylate,
GW 572016 ditosylate,
GW-572016 ditosylate,
Lapatinib Ditosylate,Tykerb,
SCHEMBL93590,
quinazolin-4-amine ditosylate,
CTK8E9246,
AOB5252,
UWYXLGUQQFPJRI-UHFFFAOYSA-N,
HMS3265I13,
HMS3265I14,
HMS3265J13,
HMS3265J14,
HMS3654E07,
LAPATINIB (DITOSYLATE SALT),
KS-00000GH3,
HY-50898A,
lapatinib bis(para-toluene sulfonate),
C29H26ClFN4O4S.2C7H8O3S,
AKOS015888607,
lapatinib; bis(p-toluenesulfonic acid),
AC-5247,
CS-0831,
GS-3661,
RTR-015625,
YF10107,
BR-47669,
SC-95137,
AB0006354,
TR-015625,
4CH-007412,
FT-0670728,
LAPATINIB, DI-P-TOLUENESULFONATE SALT,
ST24031317,
SW199101-4,
EC-000.2339,
S-4736,
GW 572016 ditosylate;GW-572016 ditosylate,
I01-1224,
SR-05000001472-2,
SR-05000001472-5,
Z1692482592,
4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-, bis(4-methylbenzenesulfonate),
4-QUINAZOLINAMINE, N-[3-CHLORO-4-[(3-FLUOROPHENYL)METHOXY]PHENYL]-6-[5-[[[2-(METHYLSULFONYL)ETHYL]AMINO]METHYL]-2-FURANYL]-, DI-4-METHYLBENZENESULFONATE,
N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfona,
N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl) ethylamino)methyl)furan-2-yl)quinazolin-4-amine ditosylate,
N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine ditosylate,
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl],
N-[3-CHLORO-4-[(3-FLUOROPHENYL)METHOXY]PHENYL]-6-[5-[(2-METHYLSULFONYLETHYLAMINO)METHYL]-2-FURYL]QUINAZOLIN-4-AMINE DITOSYLATE,
Lapatinib,
lapatinib tosilate,
LapatinibDitosylate,
LAPATINIB TOSYLATE,
Lapatinib Ditosylate [USAN],
cc-250,
UNII-G873GX646R,
388082-77-7 (ditosylate).,
GW572016F,
MFCD09264195,
LAPATINIB DITOSYLATE MONOHYDRATE,
ACN-034378,
CID9941095,
CID 9941095,
Lapatinib ditosylate, 98% - 5MG 5mg,
GW 572016,
A10514,
C29-H26-Cl-F-N4-O4-S.2C7-H8-O3-S.H2-O,
231277-92-2,
4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, 4-methylbenzenesulfonate, hydrate (2:4:1),
N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine bis(4-methylbenzenesulfonate),